PGIM India Healthcare Fund - Direct (G) - NFO
Scheme Objective
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
Fund House Details
PGIM India Mutual Fund
| Fund Name | Rating | 3 Year CAGR | 5 Year CAGR |
|---|---|---|---|
|
PGIM India Elss Tax Saver Fund - Direct Growth |
2★ | 13.22% | 19.25% |
|
PGIM India Small Cap Fund - Direct Growth |
1★ | 12.71% | - |
|
PGIM India Midcap Opportunities Fund - Dir Growth |
3★ | 12.54% | 29.71% |
|
PGIM India Balanced Advantage Fund - Direct Growth |
2★ | 10.28% | - |
|
PGIM India Large Cap Fund - Direct Growth |
1★ | 9.70% | 14.24% |
Fund House Contact Details
FAQs
The primary investment objective of the scheme is to seek to generate consistent returns by predominantly investing in equity and equity related securities of pharmaceutical and healthcare companies. However, there is no assurance that the investment objective of the scheme will be achieved. The Scheme does not guarantee/ indicate any returns.
Open date of PGIM India Healthcare Fund - Direct (G) 19 Nov 2024
Close date of PGIM India Healthcare Fund - Direct (G) 03 Dec 2024
The minimum investment amount of PGIM India Healthcare Fund - Direct (G) ₹5000
The Fund Manger of PGIM India Healthcare Fund - Direct (G) is Anandha Padmanabhan Anjen
Mutual fund Blogs
Market Outlook for 21st November 2024
Nifty Prediction for 21st November The Nifty index broke its seven-day losing streak, closing above...
Stock in Action Federal Bank 19 November 2024
Highlights 1. Federal shares saw a marginal rise, trading at ₹ 197.60 with an intraday high of ...
Onyx Biotec IPO Allotment Status
Summary Onyx Biotec IPO has closed with an extraordinary response from investors, achieving a remar...
